Blais C Jr - Search Results

1

Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.

Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T. Oyama J, et al. Among authors: blais c jr. Circulation. 2004 Feb 17;109(6):784-9. doi: 10.1161/01.CIR.0000112575.66565.84. Circulation. 2004. PMID: 14970116

2

Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure.

Lapointe N, Tsoporis JN, Parker TG, Blais C Jr, Adam A, Rouleau D, Slaughter G, Clément R, Deschepper CE, Rouleau JL. Lapointe N, et al. Among authors: blais c jr. Mol Cell Biochem. 2003 Dec;254(1-2):235-45. doi: 10.1023/a:1027328403952. Mol Cell Biochem. 2003. PMID: 14674703

3

Nitric oxide, cell death, and heart failure.

Oyama J, Frantz S, Blais C Jr, Kelly RA, Bourcier T. Oyama J, et al. Among authors: blais c jr. Heart Fail Rev. 2002 Oct;7(4):327-34. doi: 10.1023/a:1020758300499. Heart Fail Rev. 2002. PMID: 12379818 Review.

4

Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.

Lapointe N, Blais C Jr, Adam A, Parker T, Sirois MG, Gosselin H, Clément R, Rouleau JL. Lapointe N, et al. Among authors: blais c jr. J Am Coll Cardiol. 2002 May 15;39(10):1692-8. doi: 10.1016/s0735-1097(02)01837-5. J Am Coll Cardiol. 2002. PMID: 12020499 Free article.

5

Effects of captopril and omapatrilat on early post-myocardial infarction survival and cardiac hemodynamics in rats: interaction with cardiac cytokine expression.

Blais C Jr, Lapointe N, Rouleau JL, Clément R, Bachvarov DR, Adam A. Blais C Jr, et al. Can J Physiol Pharmacol. 2002 Jan;80(1):48-58. doi: 10.1139/y01-096. Can J Physiol Pharmacol. 2002. PMID: 11911226

6

Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma.

Cyr M, Lepage Y, Blais C Jr, Gervais N, Cugno M, Rouleau JL, Adam A. Cyr M, et al. Among authors: blais c jr. Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H275-83. doi: 10.1152/ajpheart.2001.281.1.H275. Am J Physiol Heart Circ Physiol. 2001. PMID: 11406494 Free article.

7

Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction.

Blais C Jr, Lapointe N, Rouleau JL, Clément R, Gervais N, Geadah D, Adam A. Blais C Jr, et al. Peptides. 2001 Jun;22(6):953-62. doi: 10.1016/s0196-9781(01)00401-6. Peptides. 2001. PMID: 11390026

8

Bradykinin metabolism and hypotensive transfusion reactions.

Cyr M, Eastlund T, Blais C Jr, Rouleau JL, Adam A. Cyr M, et al. Among authors: blais c jr. Transfusion. 2001 Jan;41(1):136-50. doi: 10.1046/j.1537-2995.2001.41010136.x. Transfusion. 2001. PMID: 11161259 Review. No abstract available.

9

The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

Blais C Jr, Marceau F, Rouleau JL, Adam A. Blais C Jr, et al. Peptides. 2000 Dec;21(12):1903-40. doi: 10.1016/s0196-9781(00)00348-x. Peptides. 2000. PMID: 11150653 Review.

10

Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts.

Blais C Jr, Fortin D, Rouleau JL, Molinaro G, Adam A. Blais C Jr, et al. J Pharmacol Exp Ther. 2000 Nov;295(2):621-6. J Pharmacol Exp Ther. 2000. PMID: 11046097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters